The clinical impact of immunoglobulin replacement therapy on severe bacterial infection for patients with hypogammaglobulinemia secondary to hematologic malignancies: A Japanese claims database study
Not Applicable
- Conditions
- hypogammaglobulinemia
- Registration Number
- JPRN-UMIN000047418
- Lead Sponsor
- CSL Behring K.K.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 125
Inclusion Criteria
Not provided
Exclusion Criteria
(1) Diagnosed with immunodeficiency (primary immunodeficiency [PID; disease code: 2793012] or human immunodeficiency virus [HIV; ICD-10 code: B20x-B24x]) during the study period. (2) Diagnosed with any other diseases* for which immunoglobulins can be used according to regulations in Japan (ICD-10 code: D693, G360, G610, G618, G700, H46x, L10x, L12x, L511, L512, M301, M303, M33x) during the study period. (3) Have a record of immunoglobulin treatment before the initial diagnosis of hypogammaglobulinemia.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method